Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly

This page shows the latest Eli Lilly news and features for those working in and with pharma, biotech and healthcare.

Lilly’s RET inhibitor Retevmo shows early promise in new cancer types

Lilly’s RET inhibitor Retevmo shows early promise in new cancer types

Trial included patients with pancreatic, colon, breast and salivary cancer. Eli Lilly has revealed new early-stage data for its RET inhibitor Retevmo in new cancer types, as the company looks ... According to Lilly, responses were ongoing in 73% of

Latest news

More from news
Approximately 136 fully matching, plus 632 partially matching documents found.

Latest Intelligence

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    The country is thus home to AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Lundbeck, MSD (Merck Sharp &Dohme), Pfizer, Sanofi and Takeda among others.

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.

  • The impact of COVID-19 on clinical trials The impact of COVID-19 on clinical trials

    Eli Lilly, Bristol-Myers Squibb and Pfizer also have multiple development programmes that are paused or delayed.

  • Working together against COVID-19 Working together against COVID-19

    A number of top pharma companies are included in the newly formed partnership, the COVID-19 Therapeutics Accelerator, including Eli Lilly, J&J, Merck, Novartis, Pfizer and Sanofi.

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    A pack of other antibody programmes involving companies including Amgen, AstraZeneca, Eli Lilly and GlaxoSmithKline is following closely behind, with multiple clinical trials scheduled to start over the summer.

More from intelligence
Approximately 4 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 7 fully matching, plus 33 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 17 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....

Infographics